Latest filing published 21 Nov 2017 for Cartesian Therapeutics, Inc., €65k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -42.3%Entry US$305.40 · Close at T+365 US$176.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Earl Sands: trading record in brief
Earl Sands has a single filing on record, published on 21 November 2017: an open-market purchase of €65k in Cartesian Therapeutics, Inc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Earl Sands
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ US$10.26100.0% of flowCommon StockSEC:0001638599-17-001158:0Canonical exit: 15 Feb 2018 (T+90)
1 of 1 declaration
